Royalty Pharma PLC

RPRX54

$27.54arrow_drop_down1.60%-$0.45

RPRX54

$27.54

arrow_drop_down1.60%-$0.45

Performance History

Key Stats
Open	$28.17
Prev. Close	$27.99
EPS	1.50

Next Earnings Date	Dec 13, 2024

	LOW	HIGH
Day Range	27.52	28.17
52 Week Range	25.20	31.65

Ratios







EPS	1.50

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Royalty Pharma PLC (RPRX)

Royalty Pharma PLC (RPRX) is a leading biopharmaceutical company that specializes in acquiring and managing royalty interests in innovative therapies. With a focus on the life sciences sector, Royalty Pharma invests in a diverse portfolio of royalties from commercial products, as well as future royalties from development-stage assets. Through its strategic partnerships with leading biotechnology companies, Royalty Pharma provides capital to support the development and commercialization of new treatments for patients around the world.

As of the latest available data, Royalty Pharma's stock price has shown a steady upward trend over the past few years. Investors have been attracted by the company's ability to generate consistent and growing royalty revenue streams from its diversified portfolio. This has resulted in a strong performance for the stock, with solid returns for shareholders. Royalty Pharma's market capitalization, which represents the total value of all its outstanding shares, has also experienced significant growth, reflecting the market's confidence in the company's business model and long-term prospects.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Pablo Gerardo Legorreta
Headquarters: New York
Employees: 0
Exchange: NASDAQ

Keep an eye on Royalty Pharma PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Royalty Pharma PLC's (RPRX) price per share?

The current price per share for Royalty Pharma PLC (RPRX) is $27.54. The stock has seen a price change of -$0.45 recently, indicating a -1.61% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Royalty Pharma PLC (RPRX)?

For Royalty Pharma PLC (RPRX), the 52-week high is $31.66, which is 14.94% from the current price. The 52-week low is $25.2, the current price is 9.29% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Royalty Pharma PLC (RPRX) a growth stock?

Royalty Pharma PLC (RPRX) has shown an average price growth of 0.41% over the past three years. It has received a score of 32 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Royalty Pharma PLC as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Royalty Pharma PLC (RPRX) stock price performance year to date (YTD)?

As of the latest data, Royalty Pharma PLC (RPRX) has a year-to-date price change of -2.58%. Over the past month, the stock has experienced a price change of -0.22%. Over the last three months, the change has been 2.34%. Over the past six months, the figure is -9.5%.

help

Is Royalty Pharma PLC (RPRX) a profitable company?

Royalty Pharma PLC (RPRX) has a net income of $1.13B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 76.19% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 50.19% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.35B, with a revenue growth rate of 5.24%, providing insight into the company's sales performance and growth. The gross profit is $1.79B. Operating income is noted at $1.49B. Furthermore, the EBITDA is $1.57B.

help

What is the market capitalization of Royalty Pharma PLC (RPRX)?

Royalty Pharma PLC (RPRX) has a market capitalization of $16.34B. The average daily trading volume is 2.49M, indicating the stock's liquidity and investor engagement.